Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Heron Therapeutics is a commercial-stage biotechnology company committed to improving the lives of patients by developing and commercializing best-in-class treatments to address unmet medical needs. Their research and development efforts are centered on creating novel, patient-focused solutions primarily in the therapeutic areas of oncology and pain management. Heron's portfolio includes FDA-approved products designed to offer significant advantages over existing therapies, aiming to enhance patient care and outcomes.
The San Diego headquarters serves as the central hub for Heron Therapeutics' corporate strategy, research and development, commercial operations, and administrative functions.
Located within a prominent life sciences campus, the headquarters features modern laboratory and office facilities designed to support cutting-edge research and foster collaboration. Its strategic location provides access to a rich ecosystem of biotech talent and resources.
Heron Therapeutics fosters a dynamic, science-driven work culture that emphasizes innovation, teamwork, and a strong commitment to improving patient lives. The environment encourages collaboration and a focus on scientific excellence.
The headquarters' location in San Diego is significant due to the city's status as a leading global biotech cluster. This provides Heron with access to top-tier talent, research institutions, and potential industry partners, which is crucial for its R&D and commercial success.
While headquartered in the United States, Heron Therapeutics aims to address patient needs globally. Its commercialized products are primarily focused on the U.S. market. The company may pursue international expansion opportunities for its approved therapies through strategic partnerships and licensing agreements to broaden patient access worldwide.
4242 Campus Point Court, Suite 200
San Diego
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, HERON' leadership includes:
HERON has been backed by several prominent investors over the years, including:
Over the past 12 months, Heron Therapeutics has actively strengthened its leadership team with key appointments, notably a new Chief Financial Officer and a new Chief Business Officer, while also experiencing some executive departures.
Discover the tools HERON uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Heron Therapeutics likely utilizes standard corporate email address formats. The most common patterns are typically [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com].
[first_initial][last]@herontx.com (e.g., jdoe@herontx.com) or [first].[last]@herontx.com (e.g., jane.doe@herontx.com)
Format
cray@herontx.com or chris.ray@herontx.com
Example
80%
Success rate
Heron Therapeutics Investor Relations / GlobeNewswire • May 9, 2024
Heron Therapeutics announced its financial results for the first quarter ended March 31, 2024. The company reported $32.1 million in net product sales, an 11% increase year-over-year, and provided updates on its commercial products and development pipeline....more
Heron Therapeutics Investor Relations / GlobeNewswire • February 13, 2024
Heron Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for ZYNRELEF® (bupivacaine and meloxicam extended-release solution) to significantly expand the indication to soft tissue and orthopedic surgical procedures....more
PR Newswire / Heron Therapeutics • January 8, 2024
Heron Therapeutics announced the appointments of Chris Ray as its Chief Financial Officer (CFO) and Brett Scott as its Chief Business Officer (CBO), effective January 8, 2024, to bolster its executive team....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including HERON, are just a search away.